A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 214 participants.
Also called NCT05643508
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 214 participants
- Registry
-
NCT05643508
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT05643508. Randomized; double masking; primary purpose treatment. Start 2023-02-23 (actual); primary completion 2024-09-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia
- Condition
- Hypertension
- Condition
- Hyperlipidemias
- Intervention (Drug)
- (D) DWC202206
- Intervention (Drug)
- (D) DWC202207
- Intervention (Drug)
- (P) DWC202206
- Intervention (Drug)
- (P) DWC202207
- Lead sponsor
- Daewoong Pharmaceutical Co. LTD.
Record details
- Record id
cardio:ct-nct05643508- Content hash
ccfcdc2121f15ef1c011821625e5b294874d74dd6f9b1f861349cd3ae8c51bc5